Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at Fox Chase Cancer Center
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Monoclonal antibodies and treatment of cancer
Hossein Borghaei
, Liat Binyamin
,
Igor Astsaturov
, Louis M. Weiner
Hematology Oncology
Cancer Epigenetics Institute
Cancer Signaling and Microenvironment (CSM)
Center for Immunology
Greenberg Pancreatic Cancer Institute
Fox Chase Cancer Center
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Monoclonal antibodies and treatment of cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Treatment
100%
Monoclonal Antibody
100%
Combination Therapy
66%
Antibody
66%
Malignant Neoplasm
33%
Cancer Therapy
33%
Cancer
33%
B Cell
33%
Aptitude
33%
CD20
33%
Breast Cancer
33%
Mechanism of Action
33%
Vasculotropin
33%
Lymphoma
33%
Rituximab
33%
Tumor Antigen
33%
Cytotoxic Agent
33%
Side Effect
33%
Epidermal Growth Factor Receptor 2
33%
Antibody Therapy
33%
Biochemistry, Genetics and Molecular Biology
Antibody
100%
Monoclonal Antibody
100%
Surface Property
33%
B Cell
33%
Vascular Endothelial Growth Factor
33%
Aptitude
33%
Epidermal Growth Factor Receptor
33%
Antigen Specificity
33%
HER2/neu
33%
CD20
33%
Rituximab
33%